Our results provide new mechanistic insights into showing that Ca2+-activated K+ channel KCa1.1 is a new downstream target of VDR signaling and the VDR stimulation enhanced the transcriptional repression of KCa1.1 and its protein degradation in human breast cancer cells. The gene discussed is VDR; the disease is breast cancer.